Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of RapamycinSteven D. Knight, Dashyant Dhanak, Christine Gardiner et al.|ACS Medicinal Chemistry Letters|2010Cited by 374
Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitorsRakesh Kumar, Andrew King, M-C Crouthamel et al.|British Journal of Cancer|2009Cited by 221
Effects of oncogenic p110α subunit mutations on the lipid kinase activity of phosphoinositide 3-kinaseJeffrey D. Carson, Lusong Luo, Glenn Van Aller et al.|Biochemical Journal|2007Cited by 119
Evidence for Allosteric Interactions of Antagonist Binding to the Smoothened ReceptorCynthia M. Rominger, David H. Rominger, Weilin Tiger Bee et al.|Journal of Pharmacology and Experimental Therapeutics|2009Cited by 63
Characterization of an exosite binding inhibitor of matrix metalloproteinase 13Lata T. Gooljarsingh, Richard R. Gontarek, Ami S. Lakdawala et al.|Protein Science|2007Cited by 43